Miltefosine for Brazilian Visceral Leishmaniasis

Status Terminated

Clinical Trial Summary

Miltefosine will be administered to Brazilian patients with kala azar

Clinical Trial Description

Miltefosine will be administered to Brazilian patients with kala azar. Both pediatric and adult patients will be studied. Patients will be followed for 6 months. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Kala Azar
Leishmaniasis
Leishmaniasis, Visceral

Clinical Trial Details

NCT number	NCT00378495
Study type	Interventional
Source	AB Foundation
Contact
Status	Terminated
Phase	Phase 1/Phase 2
Start date	April 2005
Completion date	October 2007

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT00318721` - Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar	N/A